These findings established that S100A9 was a promising diagnostic biomarker with 78% sensitivity, 88% specificity, and a 0.888 AUC value, which was equivalent values for the differential diagnosis of CCA and normal control [15]. This evidence concerns the gene S100A9 and cholangiocarcinoma.